Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (1): 45-49    DOI: 10.12891/ceog4319.2019
Original Research Previous articles | Next articles
Screening for group B hemolytic streptococcal infection in pregnancy in a low-resourced country
B. Bassaw1, *(), R. Romeo-Bassey2, A. Jaggat3, M. Manjunath2, S. Perkins2, S. Khan4
1 The University of the West Indies, St. Augustine Campus, Trinidad
2Port-of-Spain General Hospital, Port-of-Spain, Trinidad
3Westshore Medical Hospital, Port-of-Spain, Trinidad
4San Fernando General Hospital, San Fernando, Trinidad
Download:  PDF(468KB)  ( 196 ) Full text   ( 8 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objectives: The objectives of this study conducted in a low-resourced country were to determine the feasibility and acceptability among pregnant women of universal screening for group B streptococcus (GBS), the prevalence of GBS, to calculate the risk of vertical transmission, and to study the neonatal outcome of early onset group B streptococcus disease (EOGBSD). Materials and Methods: All pregnant women between 35-37 weeks of gestation who attended the Port-of-Spain General Hospital during a six-month interval were enrolled in a study involving universal screening for group B streptococcus from vaginal and ano-rectal swabs. After appropriate laboratory preparation, inspection of the plate for GBS was performed. Patients found to be GBS screen-positive received intrapartum antibiotic prophylaxis (IAP). Results: Among the 420 eligible patients, 341 women (81.2%) agreed to participate. A total of 52 maternities (15.2%) were confirmed as GBS screen-positive. The highest rate of positive results were observed in Afro-Caribbean women, although this difference was not statistically significant (p > 0.05). Intrapartum antibiotic prophylaxis (IAP) was administered to 37 patients (71.1%). Conclusion: This study reveals that despite the relatively low prevalence rate of GBS, a policy of universal screening and IAP in low-resourced countries, it is possible to address the major burden of EOGBSD.
Key words:  Group B streptococcus      Neonatal sepsis      Screening      Antibiotic prophylaxis     
Published:  10 February 2019     
*Corresponding Author(s):  B. BASSAW     E-mail:  bharath.bassaw@sta.uwi.edu

Cite this article: 

B. Bassaw, R. Romeo-Bassey, A. Jaggat, M. Manjunath, S. Perkins, S. Khan. Screening for group B hemolytic streptococcal infection in pregnancy in a low-resourced country. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 45-49.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4319.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I1/45

[1] Y.X. Wang, M. Zhong, H. Yi, H.F. He. Detection of group B streptococcus colonization in cervical and lower vaginal secretions of pregnant women[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 669-674.
[2] T. Cengiz, T. Toka Özer, F. Kılınç, R. Selimoğlu, H. Yılmaz. Candida albicans infection of cervix and comparison of Pap smear and culture in diagnosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 253-256.
[3] Yun Chen, Yunli Lai, Shang Yi, Yanqing Tang, Yaqin Lei, Sheng Yi, Yiping Shen, Hongwei Wei. Non-invasive prenatal screening for fetal aneuploidy in twin pregnancies by cell-free DNA analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 656-660.
[4] M. Durmuscan, S. Yildirmak, V. Mihmanli, Y. Gulen Cicek, M. Vardar, F. Sezgin, O. Dikker, B. Basat. A disintegrin and metalloproteinase domain-containing protein-12 levels in first-trimester pregnant women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 517-522.
[5] M. Li, L. Riming, W. Zhe, W. Hong, H. Xiaofei, C. Lina, Z. Zhengfang, W. Xuebo, W. Ning, S. Chengming, H. Qing-qing, L. Hailiang, W. Hui. Non-invasive prenatal screening for chromosome 21, 18, and 13 aneuploidies in a mixed risk factors pregnancy population[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 523-528.
[6] M. Kampioni, K. Chmaj-Wierzchowska, M. Wilczak, S. Sajdak. Prophylactic antibiotic therapy leads to the reduction of postoperative complications in colonized patients subjected to abdominal hysterectomy with/without appendages for gynaecological indications[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 529-534.
[7] A. Ferraiolo, C. Bordone, A. Ramone, P. Sala, F. Gorlero, C. Gustavino, R. Cordera. Universal versus risk factor screening for gestational diabetes mellitus[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 53-57.
[8] L. Liu, Y.M. Chen, Q.Y. Zhang, C.Z. Li. Roles of high-risk human papilloma virus (HR-HPV) E6/E7mRNA in triaging HPV16/18 cases[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 740-743.
[9] F. Hatiboğlu, S. Kumbasar, B.A. Şık, E. Sever, M. Temur, S. Salman, Ö. Çot, A. Özcan, F. Yazıcıoğlu. Maternal serum soluble CD40 ligand concentration as a predictor of preeclampsia at first trimester[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 782-786.
[10] L. Zhen, A.H. Wu, C. Liao, D.Z. Li. Prediction of homozygous α-thalassemia-1 by nuchal translucency measurement at first trimester: is it possible?[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 545-547.
[11] N. Tokgozoglu, E. Cakar, V. Sal, E. Erdogdu, A. Namazov, I. Kahramanoglu, H. Turan. Effect of borderline glucose intolerance on fetal maternal outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 562-565.
[12] K.H. Gou, X.C. Gao, L. Wang, A.Q. Yan, L. Xue, S. Han, L. Yang. Risk factors for perinatal birth defects in Zhangye: a long-term hospital-based study[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 581-583.
[13] H. Aksoy, S. Özyurt, Ü. Aksoy, Ö. Özdamar, E. Mutlu, Ş. Tutuş, M.A. Babayiğit, G. Açmaz. Interobserver reliability of sonographic fetal biometry in second trimester maternal serum screening[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 379-383.
[14] D. Balsak, O. Erol, E. Töz, A.E. Tahaoğlu, C. Toğrul, A. Eser, S. Aksin, B. Balsak. Perinatal outcomes of sonographically detected nuchal cord in southeastern Turkey[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 395-397.
[15] E.N. Yeniceri, B. Kasap, E. Akbaba, M.N. Akın, B. Sarıyıldız, M. Küçük, N. Turhan. Knowledge and attitude changes of pregnant women regarding prenatal screening and diagnostic tests after counselling[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 48-55.
No Suggested Reading articles found!